Enliven Therapeutics, Inc.
2023 Q2 - 2025 Q4 (11 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 2/13/2026 | 5,470 | 0.0% | 355,192 | 12/31/2025 |
| 2025 Q3 | 11/10/2025 | 7,435 | 0.0% | 363,202 | 9/30/2025 |
| 2025 Q2 | 8/12/2025 | 6,132 | 0.0% | 305,660 | 6/30/2025 |
| 2025 Q1 | 9/15/2025 | 5,108 | 0.0% | 259,537 | 3/31/2025 |
| 2024 Q4 | 2/6/2025 | 5,892 | 0.0% | 261,888 | 12/31/2024 |
| 2024 Q3 | 11/12/2024 | 6,520 | 0.0% | 255,277 | 9/30/2024 |
| 2024 Q2 | 8/12/2024 | 5,404 | 0.0% | 231,234 | 6/30/2024 |
| 2024 Q1 | 5/9/2024 | 2,797 | 0.0% | 159,035 | 3/31/2024 |
| 2023 Q4 | 2/6/2024 | 2,193 | 0.0% | 158,440 | 12/31/2023 |
| 2023 Q3 | 11/8/2023 | 2,140 | 0.0% | 156,631 | 9/30/2023 |
| 2023 Q2 | 8/10/2023 | 1,275 | 0.0% | 62,462 | 6/30/2023 |